Clinical Trials Browser

Terminated × Neoplasms, Plasma Cell × Thalidomide × Clear all

NCT01927718 2019-04-29

Thalidomide to Overcome Lenalidomide Resistance After Autologous Hematopoietic Stem Cell Transplantation (HCT)

Phase NA Terminated

10 enrolled 5 charts

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00538824 2018-06-06

DexTR

Phase 2 Terminated

5 enrolled 8 charts

Multiple Myeloma, Recurrence, Neoplasms, Plasma Cell

NCT00227682 2012-05-28

Arsenic Trioxide, Thalidomide, Dexamethasone, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase 2 Terminated

Multiple Myeloma, Neoplasms, Plasma Cell